Evidence map›Paper›PMID 42667545›Full record

ArticleBioresources and bioprocessing2026

Variable-specific preprocessing enables cross-scale transferable Raman models from high-throughput bioreactor data.

Sung-Hyuk Han, Jiyun Park, Kwang-Bae Lee, Cheol-Hwan Park, Dong-Yup Lee

Abstract read
In one paragraph

Article in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sung-Hyuk Han *Upstream Process Engineering, Manufacturing Science & Technology, R&D, GC Biopharma, 93 Ihyun-ro, 30beon-gil, Giheung-gu, Yongin, Gyeonggi-do, 16924, Republic of Korea. shhan85@gccorp.com.ORCID http://orcid.org/0009-0006-4914-8075
Jiyun Park *Upstream Process Engineering, Manufacturing Science & Technology, R&D, GC Biopharma, 93 Ihyun-ro, 30beon-gil, Giheung-gu, Yongin, Gyeonggi-do, 16924, Republic of Korea.
Kwang-Bae LeeUpstream Process Engineering, Manufacturing Science & Technology, R&D, GC Biopharma, 93 Ihyun-ro, 30beon-gil, Giheung-gu, Yongin, Gyeonggi-do, 16924, Republic of Korea.
Cheol-Hwan ParkSchool of Chemical Engineering, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, Republic of Korea.
Dong-Yup LeeSchool of Chemical Engineering, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, Republic of Korea. dongyuplee@skku.edu.

Funding

GC Biopharma Corp GC Biopharma CorpKorea Evaluation Institute of Industrial Technology 2410010642
6 · The paper itself

Abstract

Raman spectroscopy is increasingly used as a process analytical technology (PAT) for real-time monitoring of bioprocesses. However, chemometric models developed using high-throughput (HT) mini-bioreactor systems often show limited predictive performance when applied to larger-scale processes, reflecting an out-of-distribution (OOD) challenge in cross-scale model transfer. In this study, we investigated whether variable-specific data preprocessing strategies can improve the cross-scale prediction performance of Raman chemometric models calibrated using HT cell culture data. Multiple preprocessing approaches were systematically evaluated for key cell culture target outputs, and the optimal preprocessing pipeline for each output was selected based on its ability to minimize cross-scale prediction error. The optimized variable-specific preprocessing pipelines reduced cross-scale prediction errors by 14.0-56.1% in RMSEP across the five initially poorly transferable target outputs compared with the standard single-scale preprocessing pipeline. Consequently, these optimized single-scale models achieved predictive accuracy approaching that of resource-intensive combined-scale models. Importantly, the improvement was not dependent on a specific preprocessing technique but rather on selecting preprocessing strategies suited to the spectral characteristics of each target output. These findings suggest that intelligent preprocessing selection can mitigate out-of-distribution effects in Raman chemometric models and enable more reliable prediction across scales using HT datasets for model calibration. This approach highlights the potential of Raman spectroscopy as a practical and scalable PAT tool for industrial bioprocess development.

Indexed as

Chemometric modelingCHO cell cultureCross-scale transferabilityData preprocessingProcess analytical technology (PAT)Raman spectroscopy

Identifiers

PMID42667545
PMCPMC13526000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.